Back to funds

General Catalyst Group Management, LLC

Updated 6 days ago

Managed by General Catalyst Group Management, Llc • Latest filing Q3 2026

Portfolio value
$478.2M
Q3 2026
Filings
4
Quarterly 13F history
Top-10 concentration
100.0%
Weight of largest holdings
Annualized return
—
Implied from 13F holdings

Portfolio value history

13F-disclosed portfolio value over 4 quarters

Show data table
PeriodPortfolio value
Q4 2025$221.7M
Q1 2026$183.6M
Q2 2026$188.5M
Q3 2026$478.2M

Top holdings

13 positions as of Q3 2026

View filing
Q

QUALCOMM INC

Value
$291.4M
Shares
1.58M
% Port
60.94%
P

PARABILIS MEDICINES INC

Value
$51.7M
Shares
1.60M
% Port
10.81%
A

ARRIVENT BIOPHARMA INC

Value
$45.3M
Shares
1.49M
% Port
9.46%
C

MAPLEBEAR INC

Value
$30.6M
Shares
710.7K
% Port
6.41%
M

MAZE THERAPEUTICS INC

Value
$28.2M
Shares
1.04M
% Port
5.89%
O

ODYSSEY THERAPEUTICS INC

Value
$18M
Shares
810.3K
% Port
3.76%
O

OSCAR HEALTH INC

Value
$9.2M
Shares
299.9K
% Port
1.93%
C

COUPANG INC

Value
$1.1M
Shares
79.2K
% Port
0.23%
M

META PLATFORMS INC

Value
$957K
Shares
1.3K
% Port
0.20%
A

AMAZON COM INC

Value
$880K
Shares
3.5K
% Port
0.18%
C

CARVANA CO

Value
$548K
Shares
8.8K
% Port
0.11%
D

DOORDASH INC

Value
$239K
Shares
1.3K
% Port
0.05%
M

MARTIN MARIETTA MATLS INC

Value
$84K
Shares
175
% Port
0.02%

Explore